Former US FDA Commish Califf Endorses ‘Tortoise’ Approach To Clinical Trials

The once and likely future FDA commissioner emphasized the value of randomized controlled trials, the fact that not all trials are good for people, and how decentralization and digitization are leaving people behind during a panel discussion. 

Business, Technology, Internet and network concept. Young businessman working on a virtual screen of the future and sees the inscription: Clinical trial - Image
• Source: Shutterstock

The COVID-19 pandemic has had a dramatic impact on the way clinical trials are conducted, but industry experts caution that more needs to be done to expand the reach and success of trials.

Panelists debated the future of decentralized trials at the Galien Foundation Forum, which was held live at the Alexandria Center...

More from Clinical Trials

More from R&D